KMB

What Do Analysts Predict for KMB?

Kimberly-Clark surged to $141.39 per share this afternoon, but it remains 8.18% above its mean target price of $130.7. There may still be room for more downwards movement — even after today's 1.6% drop. Analysts are giving the large-cap Paper & Paper Products stock on average rating of hold, with target prices ranging from $118.0 to $143.0 per share.

The stock has an average amount of shares sold short at 2.2%, and a short ratio of 4.53. The company's insiders own 0.24% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 78.6% of Kimberly-Clark's shares being owned by this investor type.

Institutions Invested in Kimberly-Clark

Date Reported Holder Percentage Shares Value
2022-12-31 Vanguard Group, Inc. (The) 9% 29,578,773 $4,182,142,696
2022-12-31 Blackrock Inc. 8% 28,577,378 $4,040,555,457
2022-12-31 State Street Corporation 6% 19,252,965 $2,722,176,709
2022-12-31 Price (T.Rowe) Associates Inc 3% 9,628,171 $1,361,327,091
2022-12-31 Capital Research Global Investors 2% 7,237,222 $1,023,270,814
2022-12-31 Massachusetts Financial Services Co. 2% 7,198,665 $1,017,819,239
2022-12-31 Charles Schwab Investment Management, Inc. 2% 7,095,043 $1,003,168,125
2022-12-31 Geode Capital Management, LLC 2% 6,357,163 $898,839,272
2022-12-31 Wellington Management Group, LLP 2% 5,124,577 $724,563,938
2022-12-31 Invesco Ltd. 1% 4,891,964 $691,674,786
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS